Skip to main content
Health Care Economics

Healthcare Economics for Healthcare Professionals


Bard is committed to improving the quality of patient healthcare with essential, cost efficient medical devices that provide effective clinical outcomes. Given the financial pressures that healthcare systems are experiencing; commissioners, providers and clinicians are faced with making decisions about which services and treatments to provide and for whom. Using clinical and economic evidence, our health economics team provides comprehensive healthcare economics tools and resources to demonstrate the value of our products and assist decision makers with these difficult decisions.

In collaboration with Bard’s health economics team, the National Institute for Health and Care Excellence (NICE) has conducted an evaluation for Sherlock 3CG® Tip Confirmation System as part of the Medical Technologies Evaluation Programme. This programme identifies medical technologies that have the potential to offer substantial benefit to patients and/or to the NHS and produces guidance based on clinical and economic evidence.

The full guidance for Sherlock 3CG® Tip Confirmation System can be found on the NICE website at https://www.nice.org.uk/guidance/mtg24

NICE has also developed a Medtech Innovation Briefing (MIB) on the Lutonix® drug-coated balloon for peripheral arterial disease. MIBs are commissioned by NHS England and they provide objective information on device and diagnostic technologies to aid local decision-making by clinicians, managers and procurement professionals.

The briefings are published on the NICE website at:
https://www.nice.org.uk/advice/mib72 (Lutonix®  drug coated balloon)

UK 16-106.01